Oklo announces plans for Groves-2 ans.org

Oklo plans to build Groves-2 Forge in Texas, using lessons from its Groves test reactor to add isotope irradiation and processing, initially producing lutetium-177 for cancer treatments. The project will use DOE’s Nuclear Energy Launch Pad program and is intended to move from pilot operations to commercial production under NRC licenses; Oklo CEO Jacob DeWitte announced the plans.